J. Safra Sarasin Holding’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$409K Buy
+1,049
New +$443K 0.01% 584
2025
Q3
– Sell
-6,153
Closed -$2.36M – 510
2025
Q2
$2.36M Sell
6,153
-5,380
-47% -$1.94M 0.04% 196
2025
Q1
$3.99M Buy
11,533
+220
+2% +$70.8K 0.07% 147
2024
Q4
$3.4M Sell
11,313
-918
-8% -$321K 0.06% 162
2024
Q3
$4.97M Sell
12,231
-383
-3% -$140K 0.09% 135
2024
Q2
$4.05M Buy
+12,614
New +$4.1M 0.07% 147

Other funds holding HCA

J. Safra Sarasin Holding's HCA Position: Q2 2026 in Review

J. Safra Sarasin Holding opened a new position in HCA Healthcare (HCA) in Q2 2026: 1,049 shares worth $409K. The stake represents 0.01% of the portfolio and ranks #584 among its holdings. This is a return to the name: J. Safra Sarasin Holding previously reported a position in HCA as recently as Q2 2025.

J. Safra Sarasin Holding first reported a position in HCA in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.97M in Q3 2024. 1,342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • J. Safra Sarasin Holding held 1,049 shares of HCA Healthcare worth $409K as of Q2 2026.
  • HCA Healthcare was a new J. Safra Sarasin Holding position in Q2 2026.
  • HCA Healthcare made up 0.01% of J. Safra Sarasin Holding's portfolio in Q2 2026, its #584 holding.
  • J. Safra Sarasin Holding first reported a position in HCA Healthcare in Q2 2024 and has held it in 6 quarters since.
  • J. Safra Sarasin Holding's HCA Healthcare position peaked at $4.97M in Q3 2024.
  • 1,342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q2 2026, filed 31 Jul 2026.